Showing results (1-10 of 15) with videos related to
Sort By:
Pageof 2
Journal of Clinical Pharmacology|October 21, 2021
Use of Propensity Scoring and Its Application to Real-World Data: Advantages, Disadvantages, and Methodological Objectives Explained to Researchers Without Using Mathematical EquationsYoko FranchettiBMC Public Health|April 11, 2014
Socio-demographic and lifestyle factors for child's physical growth and adiposity rebound of Japanese children: a longitudinal study of the 21st century longitudinal survey in newbornsYoko Franchetti, Hiroo IdeJournal of Clinical Pharmacology|November 18, 2020
Dose Optimization in Kidney Disease: Opportunities for PBPK Modeling and SimulationYoko Franchetti, Thomas D NolinJournal of Clinical Pharmacology|January 18, 2021
Application of Individualized PBPK Modeling of Rate Data to Evaluate the Effect of Hemodialysis on Nonrenal Clearance PathwaysYoko Franchetti, Thomas D NolinThe Journal of Pharmacology and Experimental Therapeutics|August 11, 2019
Simultaneous Assessment of Hepatic Transport and Metabolism Pathways with a Single Probe Using Individualized PBPK Modeling of 14CO2 Production Rate DataYoko Franchetti, Thomas D NolinJournal of Biopharmaceutical Statistics|August 21, 2013
An adaptive two-stage dose-response design method for establishing proof of conceptYoko Franchetti, Stewart J Anderson, Allan R SampsonJournal of Clinical Pharmacology|May 19, 2026
Population Pharmacokinetic Modeling of Niraparib to Assess Different Absorption ModelsAnna Gaffney, Yoko Franchetti, Mathieu Desrosiers, et al.Cancer|November 23, 2013
Intraobserver and interobserver variability in computed tomography size and attenuation measurements in patients with renal cell carcinoma receiving antiangiogenic therapy: implications for alternative response criteriaKatherine M Krajewski, Mizuki Nishino, Yoko Franchetti, et al.The Oncologist|April 24, 2014
10% Tumor diameter shrinkage on the first follow-up computed tomography predicts clinical outcome in patients with advanced renal cell carcinoma treated with angiogenesis inhibitors: a follow-up validation studyKatherine M Krajewski, Yoko Franchetti, Mizuki Nishino, et al.Journal of Clinical Pharmacology|November 18, 2021
Pharmacokinetics and Concentration-Response of Dupilumab in Patients With Seasonal Allergic RhinitisMohamed A Kamal, Yoko Franchetti, Ching-Ha Lai, et al.Pageof 2